Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Paweł Rajwa

Austria

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Professors in Austria

Articles (22)

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (11)

Rui Bernardino

Cleveland Clinic Foundation

UNITED STATES

View details

Caroline M Moore

University College London

UNITED KINGDOM

View details

Veeru Kasivisvanathan

University College London

UNITED KINGDOM

View details

Malte W. Vetterlein

GERMANY

View details

Marcin Miszczyk

Narodowy Instytut Onkologii im Marii Skłodowskiej-Curie Państwowy Instytut Badawczy w Warszawie

POLAND

View details

Lorenzo Bianchi

Urologist, PhD

IRCCS Azienda Ospedaliero-Universitaria di Bologna

ITALY

View details

Giovanni Enrico Cacciamani

University of Southern California

UNITED STATES

View details

Takahiro Kimura

Jikei University School of Medicine

JAPAN

View details

Alberto Martini

Assistant Professor

University of Cincinnati

UNITED STATES

View details

Mark Emberton

University College London

UNITED KINGDOM

View details

Fabio Zattoni

Prof

University of Padova

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Paweł Rajwa

Research Interests

Make your next move.

Explore related searches

Articles (22)

Salvage Focal Therapy vs Radical Prostatectomy for Localized Radiorecurrent Prostate Cancer

First-line treatments for BCG-naïve non-muscle invasive bladder cancer

Management of lower urinary tract symptoms before prostate cancer radiotherapy

Intermediate clinical endpoints as surrogates for overall survival after salvage prostatectomy

Clinical complete response as a surrogate for pathological response in bladder cancer

Atypical intraductal proliferation in prostate biopsy — a diagnostic grey zone with clinical implications

Bayesian Evaluation of Treatment Effect of Avelumab Plus Axitinib for Advanced Renal Cell Carcinoma

Impact of Negative Prostate-specific Membrane Antigen Positron Emission Tomography on the Decision to Perform a Pelvic Lymph Node Dissection During Radical Prostatectomy for Intermediate- to High-risk Prostate Cancer Patients: Results of an International Survey

First-line therapy for metastatic renal cell carcinoma: an updated network meta-analysis using final follow-up data.

Heterogeneity in treatment effects of reduced versus standard dose of cabazitaxel in metastatic castration-resistant prostate cancer.

Perioperative immune checkpoint inhibitors combined with radical cystectomy: a rapid systematic review and meta-analysis.

Survival outcomes of patients treated with local therapy for nonmetastatic prostate cancer with high prostate‐specific antigen concentrations

Corrigendum to "Diagnostic Accuracy of Novel Urinary Biomarker Tests in Non-muscle-invasive Bladder Cancer: A Systematic Review and Network Meta-analysis" [Eur Urol Oncol 2021;4:927-42].

En bloc Resection for Bladder Tumors: An Updated Systematic Review and Meta-Analysis of Its Differential Effect on Its Safety, Recurrence, and Histopathology.

Pembrolizumab outperforms tyrosine kinase inhibitors as adjuvant treatment in patients with high-risk renal cell carcinoma after nephrectomy.

Chemotherapy is superior to checkpoint inhibitors after radical surgery for urothelial carcinoma: a systematic review and network meta-analysis of oncologic and toxicity outcomes

Discordance Between Clinical and Pathological Staging and Grading in Upper Tract Urothelial Carcinoma

Influence of steep Trendelenburg position on postoperative complications: a systematic review and meta-analysis

Preoperative plasma level of endoglin as a predictor for disease outcomes after radical cystectomy for nonmetastatic urothelial carcinoma of the bladder

Pretreatment clinical and hematologic prognostic factors of metastatic urothelial carcinoma treated with pembrolizumab: a systematic review and meta-analysis

Prognostic value of hepatocyte growth factor for muscle-invasive bladder cancer

Selection and evaluation of preoperative systemic inflammatory response biomarkers model prior to cytoreductive nephrectomy using a machine-learning approach

Collaborators (11)

Rui Bernardino

Caroline M Moore

Veeru Kasivisvanathan

Malte W. Vetterlein

Marcin Miszczyk

Lorenzo Bianchi

Giovanni Enrico Cacciamani

Takahiro Kimura

Alberto Martini

Mark Emberton

Fabio Zattoni

Make your next move.